Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current management options in Behçet's disease.

J Andrews1, D O Haskard

  • 1Rheumatology Unit, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK.

Minerva Medica
|November 1, 2002
PubMed
Summary

Behçet's disease (BD) is a rare inflammatory disorder causing ulcers and inflammation in various organs. This review covers its clinical features and current management strategies for affected individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome.

Scientific reports·2016
Same author

The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway.

Clinical and experimental immunology·2015
Same author

Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation.

Annals of the rheumatic diseases·2015
Same author

Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.

Annals of the rheumatic diseases·2014
Same author

Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma.

Oncogene·2012
Same author

Persistence of TNFalpha in diabetic wounds.

Diabetologia·2010

Area of Science:

  • Rheumatology
  • Immunology
  • Vascular Medicine

Background:

  • Behçet's disease is a multi-system inflammatory disorder.
  • Characterized by recurrent oral/genital ulcers, eye inflammation, and skin lesions.
  • May involve locomotor, vascular, neurological, and gastrointestinal systems.

Purpose of the Study:

  • To review the clinical features of Behçet's disease.
  • To discuss current management options for the disorder.
  • To enhance understanding of this rare condition.

Main Methods:

  • Literature review of clinical features.
  • Synthesis of current management strategies.
  • Analysis of pathophysiology and epidemiology.

Main Results:

  • Behçet's disease presents with diverse clinical manifestations.
  • Pathophysiology may involve generalized vascular dysfunction.
  • The condition, though rare in Western Europe, has significant morbidity and mortality.

Conclusions:

  • Comprehensive review of Behçet's disease clinical spectrum.
  • Discussion of available therapeutic approaches.
  • Highlights the need for further research into pathophysiology and management.

Related Experiment Videos